Andreas Ritsch: Publications (March 2017) 74. März W, Kleber ME

Comments

Transcription

Andreas Ritsch: Publications (March 2017) 74. März W, Kleber ME
Andreas Ritsch: Publications (March 2017)
74. März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A,
Landmesser U, Laufs U. HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol. 2017
Mar 24. Review.
73.
März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein
A, Landmesser U, Laufs U. Clinical importance of HDL cholesterol. Herz. 2016 Nov 14. Review.
72.
Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J, Dullaart RP, Eiras
S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á, Gremmel T, Hafner F, Hakala T, Huang B,
Ickmans K, Irace C, Kholová I, Kimer N, Kytö V, März W, Miazgowski T, Møller S, Montecucco F, Niccoli
G, Nijs J, Ozben S, Ozben T, Papassotiriou I, Papastamataki M, Reina-Couto M, Rios-Navarro C, Ritsch
A, Sabico S, Seetho IW, Severino A, Sipilä J, Sousa T, Taszarek A, Taurino F, Tietge UJ, Tripolino C,
Verloop W, Voskuil M, Wilding JP. Research update for articles published in EJCI in 2014. Eur J Clin
Invest. 2016 Oct;46(10):880-94. doi: 10.1111/eci.12671.
71.
Scharinger B, Messner B, Türkcan A, Schuster D, Vuorinen A, Pitterl F, Heinz K, Arnhard K,
Laufer G, Grimm M, Stuppner H, Oberacher H, Eller P, Ritsch A, Bernhard D. Leoligin, the major lignan
from edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in
ApoE -/- mice. J Mol Cell Cardiol. 2016 Aug 3. pii: S0022-2828(16)30233-4.
70.
März W, Ritsch A. Cholesterol Efflux Capacity: Choke Point of Reverse Cholesterol Traffic? J
Am Coll Cardiol. 2016 May 31;67(21):2488-91.
69.
Zhao W, Haller V, Ritsch A. The polyphenol PGG enhances expression of SR-BI and ABCA1 in
J774 and THP-1 macrophages. Atherosclerosis. 2015;242(2):611-617.
68.
Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C,
Säemann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de Las Heras Gala T,
Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, März W. Serum amyloid A:
high-density lipoproteins interaction and cardiovascular risk. Eur Heart J. 2015, in press.
67.
Ritsch A, Scharnagl H, März W. HDL Cholesterol Efflux Capacity and Cardiovascular Events. N
Engl J Med. 2015 May 7;372(19):1869-1872.
66.
Tancevski I, Nairz M, Duwensee K, Auer K, Schroll A, Heim C, Feistritzer C, Hoefer J, Gerner
RR, Moschen AR, Heller I, Pallweber P, Li X, Theurl M, Demetz E, Wolf AM, Wolf D, Eller P, Ritsch A,
Weiss G.Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via
CXCR2. EMBO Mol Med. 2014 Apr 22;6(6):810-20.
65.
Scharnagl H, Heuschneider C, Sailer S, Kleber ME, Marz W and Ritsch A. Decreased
cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levels. Eur J
Clin Invest 2014;44:395-401.
Andreas Ritsch: Publications – Page 1 of 7
64.
Silbernagel G, Schöttker B, Appelbaum S, Scharnagl H, Kleber ME, Grammer TB, Ritsch A,
Mons U, Holleczek B, Goliasch G, Niessner A, Boehm BO, Schnabel RB, Brenner H, Blankenberg S,
Landmesser U, März W. High-density lipoprotein cholesterol, coronary artery disease, and
cardiovascular mortality. Eur Heart J. 2013 Dec;34(46):3563-71.
63.
Demetz E, Tancevski I, Duwensee K, Stanzl U, Huber E, Heim C, Handle F, Theurl M, Schroll A,
Tailleux A, Dietrich H, Patsch JR, Eller P, Ritsch A. Inhibition of hepatic scavenger receptor-class B type
I by RNA interference decreases atherosclerosis in rabbits. Atherosclerosis. 2012, 222(2):360-6.
62.
Duwensee K, Schwaiger S, Tancevski I, Eller K, van Eck M, Markt P, Linder T, Stanzl U, Ritsch A,
Patsch JR, Schuster D, Stuppner H, Bernhard D, Eller P. Leoligin, the major lignan from Edelweiss,
activates cholesteryl ester transfer protein. Atherosclerosis. 2011, 219:109-15.
61.
Messner B, Zeller I, Ploner C, Frotschnig S, Ringer T, Steinacher-Nigisch A, Ritsch A, Laufer G,
Huck C, Bernhard D. Ursolic acid causes DNA-damage, P53-mediated, mitochondria- and caspasedependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in
vivo. Atherosclerosis 2011, 219:402-8.
60.
Duwensee K, Breitling LP, Tancevski I, Rothenbacher D, Demetz E, Patsch JR, Ritsch A, Eller P,
Brenner H. Cholesteryl ester transfer protein in patients with coronary heart disease. Eur J Clin
Invest. 2010 40(7):616-22.
59.
Tancevski I, Demetz E, Eller P, Duwensee K, Hoefer J, Heim C, Stanzl U, Wehinger A, Auer K,
Karer R, Huber J, Schgoer W, Van Eck M, Vanhoutte J, Fievet C, Stellaard F, Rudling M, Patsch JR,
Ritsch A. The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and
atherosclerosis development in mice. PLoS One. 2010 5(1):e8722.
58.
Ritsch A, Scharnagl H, Eller P, Tancevski I, Duwensee K, Demetz E, Sandhofer A, Boehm BO,
Winkelmann BR, Patsch JR, März W. Cholesteryl ester transfer protein and mortality in patients
undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Circulation. 2010 121(3):366-74.
57.
Petter CH, Heigl N, Bakry R, Bonn GK, Ritsch A, Huck CW. Quantification of low-density and
high-density lipoproteins in human serum by material enhanced infrared spectroscopy (MEIRS). Curr
Med Chem. 2009;16(34):4601-8.
56.
Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M,
Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A,
Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R. Gene therapy with the angiogenic cytokine
secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Circ Res.
2009 105(10):994-1002.
55.
Laimer MW, Engl J, Tschoner A, Kaser S, Ritsch A, Tatarczyk T, Rauchenzauner M, Weiss H,
Aigner F, Patsch JR, Ebenbichler CF. Effects of weight loss on lipid transfer proteins in morbidly obese
women. Lipids. 2009 44(12):1125-30.
54.
Tancevski I, Eller P, Patsch JR, Ritsch A. The resurgence of thyromimetics as lipid-modifying
agents. Curr Opin Investig Drugs. 2009 10(9):912-8
Andreas Ritsch: Publications – Page 2 of 7
53.
Messner B, Knoflach M, Seubert A, Ritsch A, Pfaller K, Henderson B, Shen YH, Zeller I, Willeit
J, Laufer G, Wick G, Kiechl S, Bernhard D. Cadmium Is a Novel and Independent Risk Factor for Early
Atherosclerosis Mechanisms and In Vivo Relevance. Arterioscler Thromb Vasc Biol. 2009 29(9):13928.
52.
Andreas Wehinger, Ivan Tancevski, Ruediger Seiler, Sandra M. Frotschnig, Stefan Frantz, Julia
Huber, Philipp Eller, Wilfried Schgoer, Bernhard Foeger, Josef R. Patsch and Andreas Ritsch. Influence
of Aspirin on SR-BI expression in human carotid plaques. Atherosclerosis. 2009 206:234-8.
51.
Tancevski I, Wehinger A, Demetz E, Hoefer J, Eller P, Huber E, Stanzl U, Duwensee K, Auer K,
Schgoer W, Kuhn V, Fievet C, Stellaard F, Rudling M, Foeger B, Patsch JR, Ritsch A. The thyromimetic
T-0681 protects from atherosclerosis. J Lipid Res. 2009 50(5):938-44.
50.
Heinrich C, Hofer A, Ritsch A, Ciardi C, Bernet S, Ritsch-Marte M. Selective imaging of
saturated and unsaturated lipids by wide-field CARS-microscopy. Opt Express. 2008 16(4):2699-708.
49.
Eller P, Schgoer W, Mueller T, Tancevski I, Demetz E, Duwensee K, Ritsch A, Haltmayer M,
Patsch JR. The K121Q polymorphism of ENPP1 and peripheral arterial disease. Heart Vessels. 2008
23(2):104-7.
48.
Tancevski I, Wehinger A, Demetz E, Eller P, Duwensee K, Huber J, Hochegger K, Schgoer W,
Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A. Reduced plasma high-density lipoprotein
cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding
cassette transporter 1 expression. Endocrinology. 2008 149(7):3708-12.
47.
Schgoer W, Eller P, Mueller T, Tancevski I, Wehinger A, Ulmer H, Sandhofer A, Ritsch A,
Haltmayer M, Patsch JR. The MTP -493TT genotype is associated with peripheral arterial disease:
results from the Linz Peripheral Arterial Disease (LIPAD) Study. Clin Biochem. 2008 41(9):712-6.
46.
Sandhofer A, Tatarczyk T, Laimer M, Ritsch A, Kaser S, Paulweber B, Ebenbichler CF, Patsch
JR. The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic
syndrome. Obesity (Silver Spring). 2008 16(4):919-22.
45.
Kern J, Bauer M, Rychli K, Wojta J, Ritsch A, Gastl G, Gunsilius E, Untergasser G. Alternative
Splicing of Vasohibin-1 Generates an Inhibitor of Endothelial Cell Proliferation, Migration, and
Capillary Tube Formation. Arterioscler Thromb Vasc Biol. 2008;28(3):478-84.
44.
Eller P, Hochegger K, Feuchtner GM, Zitt E, Tancevski I, Ritsch A, Kronenberg F, Rosenkranz
AR, Patsch JR, Mayer G. Impact of ENPP1 genotype on arterial calcification in patients with end-stage
renal failure. Nephrol Dial Transplant. 2008;23(1):321-7.
43.
Schgoer W, Mueller T, Jauhiainen M, Wehinger A, Gander R, Tancevski I, Salzmann K, Eller P,
Ritsch A, Haltmayer M, Ehnholm C, Patsch JR, Foeger B. Low phospholipid transfer protein (PLTP) is a
risk factor for peripheral atherosclerosis. Atherosclerosis. 2008;196(1):219-26.
Andreas Ritsch: Publications – Page 3 of 7
42.
Ritsch A, Sonderegger G, Sandhofer A, Stanzl U, Tancevski I, Eller P, Schgoer W, Wehinger A,
Mueller T, Haltmayer M, Patsch JR. Scavenger receptor class B type I polymorphisms and peripheral
arterial disease. Metabolism. 2007 Aug;56(8):1135-41.
41.
Egger M, Schgoer W, Beer AG, Jeschke J, Leierer J, Theurl M, Frauscher S, Tepper OM,
Niederwanger A, Ritsch A, Kearney M, Wanschitz J, Gurtner GC, Fischer-Colbrie R, Weiss G, PizaKatzer H, Losordo DW, Patsch JR, Schratzberger P, Kirchmair R. Hypoxia up-regulates the angiogenic
cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells. FASEB J.
2007;21(11):2906-17.
40.
Wehinger A, Tancevski I, Schgoer W, Eller P, Hochegger K, Morak M, Hermetter A, Ritsch A,
Patsch JR, Foeger B. Phospholipid transfer protein augments apoptosis in THP-1-derived
macrophages induced by lipolyzed hypertriglyceridemic plasma. Arterioscler Thromb Vasc Biol.
2007, 27(4):908-15.
39.
Patsch J.R. und Ritsch A. Lipide: in „Lehrbuch der Pathophysiologie“, G. Wick et al. (eds.),
2002, Maudrich Vlg., Wien.
38.
Eller P, Hochegger K, Wehinger A, Tancevski I, Schgoer W, Ritsch A, Patsch JR. Hepatic ENPP1
expression is induced in diabetic rabbits. Mamm Genome. 2006;17:886-91.
37.
Tancevski I, Ritsch A. Comment on 'Effect of atorvastatin on SR-BI expression and HDLinduced cholesterol efflux in adipocytes of hypercholesterolemic rabbits' by Zhao et al. (Clin Chim
Acta 2006; 365: 119-24). Clin Chim Acta. 2006;373:193.
36.
Marschang P, Sandhofer A, Ritsch A, Fiser I, Kvas E, Patsch JR. Plasma cholesteryl ester
transfer protein concentrations predict cardiovascular events in patients with coronary artery disease
treated with pravastatin. J Intern Med. 2006;260:151-9.
35.
Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, Patsch JR, Ebenbichler CF.
Cholesteryl ester transfer protein in metabolic syndrome. Obesity. 2006;14:812-8.
34.
Tancevski, I., Wehinger, A., Schgoer, W., Eller, P., Cuzzocrea, S., Foeger, B., Patsch, J.R., and
Ritsch, A. 2006. Aspirin regulates expression and function of scavenger receptor-BI in macrophages:
studies in primary human macrophages and in mice. The FASEB Journal 2006;20:1328-1335.
33.
Tancevski, I., Wehinger, A., Patsch, J.R., and Ritsch, A. 2006. In vivo application of adenoviral
vectors purified by a Taqman Real Time PCR-supported chromatographic protocol. Int J Biol
Macromol. 2006;39:77-82.
32.
Eller P, Schgoer W, Mueller T, Tancevski I, Wehinger A, Ulmer H, Foeger B, Haltmayer M,
Ritsch A, Patsch JR. Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J
Intern Med. 2005;258(4):344-8
31.
Tancevski, I., Frank, S., Massoner, P., Stanzl, U., Schgoer, W., Wehinger, A., Fievet, C., Eller, P.,
Patsch, J.R., and Ritsch, A. 2005. Increased plasma levels of LDL cholesterol in rabbits after adenoviral
overexpression of human scavenger receptor class B type I. J Mol Med 83:927-932.
Andreas Ritsch: Publications – Page 4 of 7
30.
Niederwanger A, Kranebitter M, Ritsch A, Patsch JR, Pedrini MT. A gel filtration assay to
determine glycogen synthase activity. J Chromatogr B Analyt Technol Biomed Life Sci
2005;820(1):143-5.
29.
Ritsch A, Ebenbichler CF, Naschberger L, Schgör W, Stanzl U, Dietrich H, Heinrich PC und
Patsch JR. Phage Displayed Recombinant Single-Chain Antibody Fragments with High Affinity for
Cholesteryl Ester Transfer Protein: cDNA Cloning, Characterization and CETP Quantification. Clin
Chem Lab Med 2004;42:247-55.
28.
Haller T, Dietl P, Stockner H, Frick M, Mair N, Tinhofer I, Ritsch A, Enhorning G, Putz G.
Tracing surfactant transformation from cellular release to insertion into an air-liquid interface. Am J
Physiol Lung Cell Mol Physiol. 2004;286:1009-15.
27.
Kirchmair R, Gander R, Egger M, Hanley A, Silver M, Ritsch A, Murayama T, Kaneider N, Sturm
W, Kearny M, Fischer-Colbrie R, Kircher B, Gaenzer H, Wiedermann C, Ropper AH, Losordo DW,
Patsch JR und Schratzberger P. The neuropeptide secretoneurin acts as a direct angiogenic cytokine
in vitro and in vivo. Circulation 2004;109:777-83.
26.
Ritsch A, Tancevski I, Schgoer W, Pfeifhofer C, Gander R, Eller P, Foeger B, Stanzl U und J.R.
Patsch JR. Molecular Characterization of Rabbit Scavenger Receptor Class B Type I and II: Portal to
Central Vein Gradient of Expression in the Liver; J Lipid Res. 2004;45:214-22.
25.
Ritsch A, Patsch JR. Cholesteryl ester transfer protein: gathering momentum as a genetic
marker and as drug target. Curr Opin Lipidol. 2003;14:173-179
24.
Ebenbichler CF, Laimer M, Kaser S, Ritsch A, Sandhofer A, Weiss H, Aigner F, Patsch JR.
Relationship between cholesteryl ester transfer protein and atherogenic lipoprotein profile in
morbidly obese women. Arterioscler Thromb Vasc Biol. 22:1465-1469, 2002.
23.
Andreas Ritsch, Susanne Kaser, Birgit Volgger, Elisabeth Abfalter, Wolfgang Sturm, Hannes
Gänzer, Bernhard Föger, Rudolf Kirchmair, Christoph Ebenbichler, and Josef R. Patsch. Enhancement
of Cholesteryl Ester Transfer in Plasma by Hormone Replacement Therapy. Metabolism 51:599-604,
2002.
22.
Roland Gander, Philipp Eller, Susanne Kaser, Igor Theurl, Doris Walter, Teresa Sauper,
Andreas Ritsch, Josef R. Patsch and Bernhard Föger. Molecular Characterization of Rabbit PLTP:
Choroid Plexus and Ependyma Synthesize High Levels of PLTP. J Lipid Res 43:636-45, 2002.
21.
Geltner C, Lechleitner M, Föger B, Ritsch A, Drexel H, Patsch JR. Insulin improves fasting and
postprandial lipemia in type II diabetes. Eur J Intern Med 13:256-263, 2002.
20.
Gaenzer H, Sturm W, Neumayr G, Kirchmair R, Ebenbichler C, Ritsch A, Foger B, Weiss G,
Patsch JR. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial
artery in men. Cardiovasc Res 52: 509-16, 2001.
19.
Kaser S, Foger B, Ebenbichler CF, Kirchmair R, Gander R, Ritsch A, Sandhofer A, Patsch JR.
Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int J
Obes Relat Metab Disord 25: 1633-9, 2001.
Andreas Ritsch: Publications – Page 5 of 7
18.
C.F. Ebenbichler, W. Sturm, H. Gänzer, J. Bodner, B. Mangweth, A. Ritsch, A. Sandhofer, M.
Lechleitner, B. Föger, J.R. Patsch. Flow-mediated, endothelium dependent vasodilation is impaired in
male body builders taking anabolic-androgenic steroids. Atherosclerosis 158: 483-90, 2001.
17.
Susanne Kaser, Christoph F. Ebenbichler, Hans J. Wolf, Anton Sandhofer, Ursula Stanzl,
Andreas Ritsch, Josef R. Patsch. Lipoprotein profile and cholestery ester transfer protein in neonates.
Metabolism 50: 723-8, 2001.
16.
Andreas Ritsch and Josef R. Patsch. Detecting cholesteryl ester transfer protein in plasma: in
Methods in Molecular Medicine, vol. 52: Atherosclerosis: Experimental Mehods and Protocols, A.F.
Drew (ed), 2000, Totowa, NJ.
15.
Gänzer H, Sturm W, Kirchmair R, Neumayr G, Ritsch A, Patsch JR. Circadian variation of
endothelium-dependent vasodilatation of the brachial artery as a confounding factor in the
evaluation of endothelial function, Atherosclerosis 149: 227-228, 2000 (Letter).
14.
Andreas Ritsch and Josef R. Patsch. Detection of gene defects in lipoprotein metabolism,
Journal of Laboratory Medicine 24: 254-261, 2000.
13.
Föger B, Königsrainer A, Ritsch A, Lechleitner M, Steurer W, Margreiter R, Patsch JR: Pancreas
transplantation modulates reverse cholesterol transport, Transplant International 12: 360-364,
1999.
12.
Andreas Ritsch, Wolfgang Doppler, Christa Pfeifhofer, Anton Sandhofer, Johannes Bodner,
and Josef R. Patsch. Cholesteryl ester transfer protein gene expression is not specifically regulated by
CCAAT/Enhancer-binding Protein in HepG2-cells. Atherosclerosis 146: 11-8, 1999.
11.
Johannes Bodner, Christoph F. Ebenbichler, Monika Lechleitner, Andreas Ritsch, Anton
Sandhofer, Roland Gander, Hans J. Wolf, Otto Huber und Josef R. Patsch. Leptin - Eine
Zwischenbilanz. Wien Klin Wochenschr: 110/6: 212-219, 1998.
10.
Andreas Ritsch, Heinz Drexel, Franz W. Amann, Christa Pfeifhofer, and Josef. R. Patsch.
Deficiency of cholesteryl ester transfer protein due to a novel molecular defect: Dissociation of
transport of cholesteryl esters and triglycerides in plasma. Arteriosclerosis and Thrombosis: 17:
3433-3441, 1997.
9.
Föger B., Ritsch A., Doblinger A., Wessels H., and J.R. Patsch. Relationship of plasma
cholesteryl ester transfer protein to HDL cholesterol: studies in normotriglyceridemia and moderate
hypertriglyceridemia. Arteriosclerosis and Thrombosis: 16(12): 1430-1436, 1996.
8.
Föger B, A. Königsrainer, G. Palos, A. Ritsch, G. Tröbinger, H.-J. Menzel, M. Lechleitner, A.
Doblinger, P. König, G. Utermann, R. Margreiter, and J.R. Patsch. Effects of Pancreas Transplantation
on Distribution and Composition of Plasma Lipoproteins. Metabolism: 45: 856-861, 1996.
7.
B. Föger, G. Luef, A. Ritsch, C. Schmidauer, A. Doblinger, M. Lechleitner, F. Aichner, and J.R.
Patsch. Relationship of high density lipoprotein subfractions and cholesteryl ester transfer protein in
plasma to carotid artery wall thickness. J. Mol. Med. 73: 369-372, 1995.
Andreas Ritsch: Publications – Page 6 of 7
6.
Bernhard Föger, Gabriele Tröbinger, Andreas Ritsch, Monika Lechleitner, Thomas
Hopferwieser, Hans-Jürgen Menzel, Gert Utermann, Karl P. Pfeiffer, and Josef R. Patsch. Treatment of
primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes,
postprandial lipoprotein metabolism, and lipoprotein distribution and composition. Atherosclerosis
117: 253-261, 1995.
5.
Bernhard Föger, Alfred Königsrainer, Gabor Palos, Eduard Brandstätter, Andreas Ritsch, Paul
König, Gero Miesenböck, Monika Lechleitner, Raimund Margreiter, and Josef R. Patsch. Effect of
pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
Transplantation 58: 899-904, 1994.
4.
B. Föger, H. Drexel, Th. Hopferwieser, G. Miesenböck, A. Ritsch, M. Lechleitner, G. Tröbinger,
and J.R. Patsch. Fenofibrate improves postprandial chylomicron clearance in II B
hyperlipoproteinemia. Clin Investig 72: 294-301, 1994.
3.
Bernhard Föger, Thomas Wohlfarter, Andreas Ritsch, Monika Lechleitner, Carl H. Miller,
Anton Dienstl and Josef R. Patsch. Kinetics of Lipids, Apolipoproteins and Cholesteryl Ester Transfer
Protein in Plasma after a Bicycle Marathon. Metabolism 43: 633-639, 1994.
2.
Hiro-Omi Mowri, Josef R. Patsch, Andreas Ritsch, Bernhard Föger, Spencer Brown, and
Wolfgang Patsch. High density lipoproteins with differing apolipoproteins: relationships to
postprandial lipemia, cholesteryl ester transfer protein and activities of lipoprotein lipase, hepatic
lipase and lecithin:cholesterol acyltransferase. J Lipid Res 35: 291-300, 1994.
1.
Andreas Ritsch, Bernhard Auer, Bernhard Föger, Siegfried Schwarz, and Josef R.
Patsch.Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester
transfer protein. J Lipid Res 34: 673-679, 1993.
Andreas Ritsch: Publications – Page 7 of 7

Similar documents